Cargando…
Cancer genomic medicine in Japan
Advances in cancer research have revolutionized the way cancer is diagnosed and treated. Any cancer is now known to be an amalgamation of many subtypes, each carrying its specific cancer-causing gene or oncogene. It is also evident that a given oncogene is often present across a wide range of cancer...
Autor principal: | MANO, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Academy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443380/ https://www.ncbi.nlm.nih.gov/pubmed/32788553 http://dx.doi.org/10.2183/pjab.96.023 |
Ejemplares similares
-
C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan
por: Kohno, Takashi, et al.
Publicado: (2022) -
Establishment and implementation of Cancer Genomic Medicine in Japan
por: Mukai, Yosuke, et al.
Publicado: (2021) -
Implementation of “clinical sequencing” in cancer genome medicine in Japan
por: Kohno, Takashi
Publicado: (2018) -
Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine
por: Nagahashi, Masayuki, et al.
Publicado: (2016) -
Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan
por: TAKAYANAGI, Shunsaku, et al.
Publicado: (2017)